Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för hellebrigenin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

10 träffar

Bibliografisk träff 2023-12-29

Hellebrigenin triggers death of promyelocytic leukemia cells by non-genotoxic ways.

Cavalcanti BC, Soares BM, Barreto FS, Magalhães HIF, Ferreira JRO, Almeida ATA, Araújo Beserra Filho JI, Silva J, Dos Santos HS, Marinho ES, Furtado CLM, Moraes Filho MO, Pessoa C, Ferreira PMP.

Toxicon · journal article · DOI 10.1016/j.toxicon.2023.107591

Bibliografisk träff 2023-12-03

Hellebrigenin induces oral cancer cell apoptosis by modulating MAPK signalling and XIAP expression.

Hsieh MJ, Lin CC, Lo YS, Ho HY, Chuang YC, Chen MK.

J Cell Mol Med · research support, non-u.s. gov't; research-article; journal article · DOI 10.1111/jcmm.18071

Bibliografisk träff 2021-08-26

Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells.

Zhang Y, Yuan B, Bian B, Zhao H, Kiyomi A, Hayashi H, Iwatani Y, Sugiura M, Takagi N.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2021.711220

Bibliografisk träff 2020-05-08

Hellebrigenin anti-pancreatic cancer effects based on apoptosis and autophage.

Wei X, He J, Gao B, Han L, Mao Y, Zhao H, Si N, Wang H, Yang J, Bian B.

PeerJ · research-article; journal article · DOI 10.7717/peerj.9011

Bibliografisk träff 2018-09-20

Cytocidal effects of arenobufagin and hellebrigenin, two active bufadienolide compounds, against human glioblastoma cell line U-87.

Han L, Yuan B, Shimada R, Hayashi H, Si N, Zhao HY, Bian B, Takagi N.

Int J Oncol · research-article; journal article · DOI 10.3892/ijo.2018.4567

Bibliografisk träff 2014-06-20

Hellebrigenin induces cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells through inhibition of Akt.

Deng LJ, Hu LP, Peng QL, Yang XL, Bai LL, Yiu A, Li Y, Tian HY, Ye WC, Zhang DM.

Chem Biol Interact · research support, non-u.s. gov't; journal article · DOI 10.1016/j.cbi.2014.06.003

Bibliografisk träff 2013-04-26

Hellebrin and its aglycone form hellebrigenin display similar in vitro growth inhibitory effects in cancer cells and binding profiles to the alpha subunits of the Na+/K+-ATPase.

Moreno Y Banuls L, Katz A, Miklos W, Cimmino A, Tal DM, Ainbinder E, Zehl M, Urban E, Evidente A, Kopp B, Berger W, Feron O, Karlish S, Kiss R.

Mol Cancer · research-article; journal article · DOI 10.1186/1476-4598-12-33

Bibliografisk träff 1984-01-01

[The pharmacology of a new cardiosteroid, a partially synthetic derivative of the aglycone hellebrigenin (acrihellin)].

Stroman F, Jakovlev V, Metzenauer P, Roth E, Thiemer K.

Arzneimittelforschung · journal article; english abstract

Bibliografisk träff 1969-11-01

[Biogenesis of steroid derivatives in the plant kingdom. 14. Hydroxylation in the 5-position during the biogenesis of hellebrigenin].

Tschesche R, Scholten H, Peters M.

Z Naturforsch B · journal article · DOI 10.1515/znb-1969-1135

Bibliografisk träff 1968-03-01

Hellebrigenin 3-haloacetates: potent site-directed alkylators of transport adenosinetriphosphatase.

Ruoho AE, Hokin LE, Hemingway RJ, Kupchan SM.

Science · journal article · DOI 10.1126/science.159.3821.1354